Edgecortix Funding: $110M Raised, Series B (2025)

Edgecortix funding overview

Edgecortix is based in Tokyo, Japan. Edgecortix has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in November 2025. The round record for Edgecortix runs through 2025; nothing later has been disclosed. Investors on record include TDK Ventures, CDIB Cross Border Innovation Fund II LP (CCBI), Jane Street Global Trading, Yanmar Ventures, Pacific Bays Capital, NTT Finance Corporation and 4 others. 10 distinct backers are named across the disclosed rounds.

Edgecortix at a glance

Total raised: $110M
Latest round: Series B
Latest round date: November 2025
Headquarters: Tokyo, Japan
Notable investors: TDK Ventures, CDIB Cross Border Innovation Fund II LP (CCBI), Jane Street Global Trading, Yanmar Ventures, Pacific Bays Capital, NTT Finance Corporation, SiC Power, Aero X Ventures

Frequently asked about Edgecortix funding

How much has Edgecortix raised?: Edgecortix has raised $110M in total disclosed funding across the rounds on record.
Who has invested in Edgecortix?: TDK Ventures, CDIB Cross Border Innovation Fund II LP (CCBI), Jane Street Global Trading, Yanmar Ventures, Pacific Bays Capital, NTT Finance Corporation are named among the investors backing Edgecortix.
What was the latest Edgecortix funding round?: The most recent disclosed round is a Series B, announced in November 2025.
Where is Edgecortix based?: Edgecortix is based in Tokyo, Japan.
When did Edgecortix last raise?: The last disclosed Edgecortix round closed in November 2025 at Series B.

Every Edgecortix figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Tokyo at a similar stage.

Edgecortix Funding: $110M Raised, Series B (2025)

Edgecortix funding overview

Edgecortix at a glance

Frequently asked about Edgecortix funding

Companies related to Edgecortix (32)

Browse related funding lists (6)